Trial Profile
Clinical Trials Insight: 700026202
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Jan 2010
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors NeoPharm Inc
- 07 Jan 2010 Status changed from active, no longer recruiting to completed.
- 07 Jan 2010 Results reported in a NeoPharm media release.
- 20 Aug 2007 New trial record.